Session: Neutropenia

Moderator: Prof. dr Ana Vidović, Panelists: Prof. dr Nada Suvajdžić, Prof. dr Aleksandar Savić

EET Opening remarks

How we can treat unfit AML patients?

Treating unfit acute myeloid leukemia (AML) patients, who may have poor overall health or multiple comorbidities that make them unable to tolerate aggressive treatments, can be challenging. The goal in treating unfit patients is often to balance the potential benefits of therapy with the risks associated with treatment-related complications...

Panel discussion /All speakers

Panel discussion for EET Session 1: Acute myeloid leukemia - Diagnosis & therapy

Closing remarks